PHARMACEUTICAL PREPARATIONS TREATING HUMAN

Brand Owner (click to sort) Address Description
ABRACEDE MERCK SHARP & DOHME CORP. Office of General Counsel One Merck Drive Whitehouse Station NJ 08889 pharmaceutical preparations for treating human immune diseases and conditions;
BIO-TROPIN Bio-Technology General Corp. 70 Wood Avenue South Iselin NJ 08830 pharmaceutical preparations for treating human growth hormone deficiency;
BIO-TROPIN Bio-Technology General Corp. 70 Wood Avenue South Iselin NJ 08830 PHARMACEUTICAL PREPARATIONS FOR TREATING HUMAN GROWTH HORMONE DEFICIENCY;
BRENZYS MERCK SHARP & DOHME CORP. Office of General Counsel One Merck Drive Whitehouse Station NJ 08889 pharmaceutical preparations for treating human immune diseases and conditions;
BRENZYS N.V. ORGANON KLOOSTERSTRAAT 6 OSS 5349AB Netherlands pharmaceutical preparations for treating human immune diseases and conditions;
ENBEQUA Coherus Biosciences, Inc. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 Pharmaceutical preparations for treating human immune diseases and conditions;
ENBREL IMMUNEX CORPORATION One Amgen Center Drive Thousand Oaks CA 913201799 pharmaceutical preparations for treating human immune diseases and conditions;
ERFENZA MERCK SHARP & DOHME CORP. Office of General Counsel One Merck Drive Whitehouse Station NJ 08889 Pharmaceutical preparations for treating human immune diseases and conditions;
ETAMUVO Lupin Healthcare (UK) Limited THE URBAN BUILDING SECOND FLOOR 3-9 ALBERT STREET SLOUGH, BERKSHIRE SL 1 2BE United Kingdom Pharmaceutical preparations for treating human immune diseases and conditions;
ETAMUVO Lupin (Europe) Limited Suite 1, Victoria Court Bexton Road Knutsford, Cheshire WA160PF United Kingdom Pharmaceutical preparations for treating human immune diseases and conditions;
ETANFIA MERCK SHARP & DOHME CORP. Office of General Counsel One Merck Drive Whitehouse Station NJ 08889 pharmaceutical preparations for treating human immune diseases and conditions;
ETANFIA N.V. ORGANON KLOOSTERSTRAAT 6 OSS 5349AB Netherlands Pharmaceutical preparations for treating human immune diseases and conditions;
FREEDOM TO MOVE ON IMMUNEX CORPORATION One Amgen Center Drive Thousand Oaks CA 913201799 Pharmaceutical preparations for treating human immune diseases and conditions;
JULANT IMMUNEX CORPORATION One Amgen Center Drive Thousand Oaks CA 913201799 Pharmaceutical preparations for treating human immune and inflammatory diseases and conditions;
MOBIST IMMUNEX CORPORATION One Amgen Center Drive Thousand Oaks CA 913201799 pharmaceutical preparations for treating human diseases and medical conditions, namely, cancer, infectious diseases, aids, and for use as a vaccine adjuvant;
MOBISTA IMMUNEX CORPORATION One Amgen Center Drive Thousand Oaks CA 913201799 Pharmaceutical preparations for treating human diseases and medical conditions, namely, cancer, infectious diseases, AIDS, and for use as a vaccine adjuvant;
NORMUNITY Normunity, Inc. 285 Riverside Avenue, Suite 250 Westport CT 06880 Pharmaceutical preparations for treating human diseases;Medical and scientific research in the field of human diseases; Pharmaceutical research and development;
RYMTI Lupin Healthcare (UK) Limited THE URBAN BUILDING SECOND FLOOR 3-9 ALBERT STREET SLOUGH, BERKSHIRE SL 1 2BE United Kingdom Pharmaceutical preparations for treating human immune diseases and conditions;
SIMBRELOS Lupin Healthcare (UK) Limited THE URBAN BUILDING SECOND FLOOR 3-9 ALBERT STREET SLOUGH, BERKSHIRE SL 1 2BE United Kingdom Pharmaceutical preparations for treating human immune diseases and conditions;
SYMETAN Therapeutic Proteins International Suite 300 3440 S. Dearborn Street Chicago IL 60616 pharmaceutical preparations for treating human immune diseases and conditions;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.